BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/11/2024 2:35:35 PM | Browse: 271 | Download: 1043
 |
Received |
|
2024-01-07 08:13 |
|
Peer-Review Started |
|
2024-01-07 08:13 |
|
First Decision by Editorial Office Director |
|
2024-01-20 07:08 |
|
Return for Revision |
|
2024-01-20 07:08 |
|
Revised |
|
2024-02-01 08:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-03-25 01:21 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-03-25 05:30 |
|
Articles in Press |
|
2024-03-25 05:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-26 11:05 |
|
Publish the Manuscript Online |
|
2024-06-11 14:35 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Editorial |
| Article Title |
New perspectives in the management of diabetic nephropathy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anna Psyllaki and Konstantinos Tziomalos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Konstantinos Tziomalos, MD, MSc, PhD, Associate Professor, The First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, Thessaloniki 54636, Greece. ktziomal@auth.gr |
| Key Words |
Diabetes mellitus; Diabetic nephropathy; Sodium-glucose cotransporter 2 inhibitors; Finerenone; Glucagon-like peptide 1 receptor agonists; Finerenone |
| Core Tip |
The management of diabetic nephropathy evolved substantially in recent years with the accumulation of evidence showing that sodium-glucose cotransporter 2 inhibitors and potentially finerenone prevent both renal function deterioration and cardiovascular events. |
| Publish Date |
2024-06-11 14:35 |
| Citation |
Psyllaki A, Tziomalos K. New perspectives in the management of diabetic nephropathy. World J Diabetes 2024; 15(6): 1086-1090
|
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i6/1086.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v15.i6.1086 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
